Literature DB >> 30594678

Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview.

Suvankar Banerjee1, Nilanjan Adhikari1, Sk Abdul Amin1, Tarun Jha2.   

Abstract

The histone deacetylases (HDACs) enzymes provided crucial role in transcriptional regulation of cells through deacetylation of nuclear histone proteins. Discoveries related to the HDAC8 enzyme activity signified the importance of HDAC8 isoform in cell proliferation, tumorigenesis, cancer, neuronal disorders, parasitic/viral infections and other epigenetic regulations. The pan-HDAC inhibitors can confront these conditions but have chances to affect epigenetic functions of other HDAC isoforms. Designing of selective HDAC8 inhibitors is a key feature to combat the pathophysiological and diseased conditions involving the HDAC8 activity. This review is concerned about the structural and positional aspects of HDAC8 in the HDAC family. It also covers the contributions of HDAC8 in the pathophysiological conditions, a preliminary discussion about the recent scenario of HDAC8 inhibitors. This review might help to deliver the structural, functional and computational information in order to identify and design potent and selective HDAC8 inhibitors for target specific treatment of diseases involving HDAC8 enzymatic activity.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer; HDAC8; HDAC8 inhibitor; Histone deacetylase; Quantitative structure-activity relationship (QSAR); Structure-activity relationship (SAR)

Mesh:

Substances:

Year:  2018        PMID: 30594678     DOI: 10.1016/j.ejmech.2018.12.039

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  14 in total

1.  Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation.

Authors:  Neha Upadhyay; Kalpana Tilekar; Niklas Jänsch; Markus Schweipert; Jessica D Hess; Luca Henze Macias; Piotr Mrowka; Renato J Aguilera; Jun-Yong Choe; Franz-Josef Meyer-Almes; C S Ramaa
Journal:  Bioorg Chem       Date:  2020-05-15       Impact factor: 5.275

Review 2.  A Genetically Encoded, Phage-Displayed Cyclic-Peptide Library.

Authors:  Xiaoshan Shayna Wang; Peng-Hsun Chase Chen; J Trae Hampton; Jeffery M Tharp; Catrina A Reed; Sukant K Das; Duen-Shian Wang; Hamed S Hayatshahi; Yang Shen; Jin Liu; Wenshe Ray Liu
Journal:  Angew Chem Int Ed Engl       Date:  2019-09-09       Impact factor: 15.336

3.  Validation of HDAC8 Inhibitors as Drug Discovery Starting Points to Treat Acute Kidney Injury.

Authors:  Keith Long; Zoe Vaughn; Michael David McDaniels; Sipak Joyasawal; Aneta Przepiorski; Emily Parasky; Veronika Sander; David Close; Paul A Johnston; Alan J Davidson; Mark de Caestecker; Neil A Hukriede; Donna M Huryn
Journal:  ACS Pharmacol Transl Sci       Date:  2022-03-16

4.  Synthesis and HDAC inhibitory activity of pyrimidine-based hydroxamic acids.

Authors:  Virginija Jakubkiene; Gabrielius Ernis Valiulis; Markus Schweipert; Asta Zubriene; Daumantas Matulis; Franz-Josef Meyer-Almes; Sigitas Tumkevicius
Journal:  Beilstein J Org Chem       Date:  2022-07-13       Impact factor: 2.544

Review 5.  The Chemical Biology of Reversible Lysine Post-translational Modifications.

Authors:  Zhipeng A Wang; Philip A Cole
Journal:  Cell Chem Biol       Date:  2020-07-21       Impact factor: 8.116

Review 6.  The function of histone acetylation in cervical cancer development.

Authors:  Shanshan Liu; Weiqin Chang; Yuemei Jin; Chunyang Feng; Shuying Wu; Jiaxing He; Tianmin Xu
Journal:  Biosci Rep       Date:  2019-04-12       Impact factor: 3.840

7.  Design and synthesis of diazine-based panobinostat analogues for HDAC8 inhibition.

Authors:  Sivaraman Balasubramaniam; Sajith Vijayan; Liam V Goldman; Xavier A May; Kyra Dodson; Sweta Adhikari; Fatima Rivas; Davita L Watkins; Shana V Stoddard
Journal:  Beilstein J Org Chem       Date:  2020-04-07       Impact factor: 2.883

8.  Synthesis and Biological Evaluation of HDAC Inhibitors With a Novel Zinc Binding Group.

Authors:  Junquan He; Songsong Wang; Xingang Liu; Ruili Lin; Fang Deng; Zhong Jia; Chenghong Zhang; Zhao Li; Hongtian Zhu; Lei Tang; Pingrong Yang; Dian He; Qingzhong Jia; Yang Zhang
Journal:  Front Chem       Date:  2020-04-15       Impact factor: 5.221

Review 9.  Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs).

Authors:  Yuxiang Luo; Huilin Li
Journal:  Int J Mol Sci       Date:  2020-11-22       Impact factor: 5.923

Review 10.  Challenges Faced with Small Molecular Modulators of Potassium Current Channel Isoform Kv1.5.

Authors:  Zefeng Zhao; Songsong Ruan; Xiaoming Ma; Qian Feng; Zhuosong Xie; Zhuang Nie; Peinan Fan; Mingcheng Qian; Xirui He; Shaoping Wu; Yongmin Zhang; Xiaohui Zheng
Journal:  Biomolecules       Date:  2019-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.